The surfaceassociated exopolysaccharide of Bifidobacterium longum 35624 plays an essential role in dampening host proinflammatory responses and repressing local TH17 responses

Applied and Environmental Microbiology

Volumn 82, Issue 24, 2016, Pages 7185-7196

  Schiavi, Elisa ^a,b   Gleinser, Marita ^c   Molloy, Evelyn ^c   Groeger, David ^b   Frei, Remo ^a   Ferstl, Ruth ^a   Rodriguez Perez, Noelia ^a   Ziegler, Mario ^a   Grant, Ray ^b   Moriarty, Thomas Fintan ^d   Plattner, Stephan ^b   Healy, Selena ^b   Motherway, Mary O'Connell ^c   Akdis, Cezmi A ^a   Roper, Jennifer ^b   Altmann, Friedrich ^e   Sinderen, Douwe van ^c   O'Mahony, Liam ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b ALIMENTARY HEALTH LTD   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

^d AO RESEARCH INSTITUTE   (Switzerland)

^e UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; DISEASES; ENZYME ACTIVITY; METABOLITES;

BIFIDOBACTERIUM LONGUM; CYTOKINE SECRETIONS; EXOPOLYSACCHARIDES; GENETIC COMPLEMENTATION; HOST IMMUNE RESPONSE; HUMAN DENDRITIC CELLS; MOLECULAR CHARACTERISTICS; PROINFLAMMATORY RESPONSE;

T-CELLS;

BACTERIUM; CELLS AND CELL COMPONENTS; DISEASE; IMMUNE RESPONSE; MUTATION; POLYSACCHARIDE; RODENT; SECRETION; SYMPTOM;

BIFIDOBACTERIUM LONGUM; MURINAE; MUS;

BACTERIAL POLYSACCHARIDE; CYTOKINE; INTERLEUKIN 17;

ANIMAL; BAGG ALBINO MOUSE; BIFIDOBACTERIALES INFECTION; BIFIDOBACTERIUM LONGUM; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; MICROBIOLOGY; MOUSE; TH17 CELL;

ANIMALS; BIFIDOBACTERIALES INFECTIONS; BIFIDOBACTERIUM LONGUM; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-17; MICE; MICE, INBRED BALB C; POLYSACCHARIDES, BACTERIAL; TH17 CELLS;

EID: 84997482223     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.02238-16     Document Type: Article

References (55)

1. Donaldson GP, Lee SM, Mazmanian SK. 2016. Gut biogeography of the bacterial microbiota. Nat Rev Microbiol 14:20-32. http://dx.doi.org/10.1038/nrmicro3552.
2. Marchesi JR, Adams DH, Fava F, Hermes GDA, Hirschfield GM, Hold G, Quraishi MN, Kinross J, Smidt H, Tuohy KM, Thomas LV, Zoetendal EG, Hart A. 2016. The gut microbiota and host health: a new clinical frontier. Gut 65:330-339. http://dx.doi.org/10.1136/gutjnl-2015-309990.
3. Frei R, Lauener RP, Crameri R, O'Mahony L. 2012. Microbiota and dietary interactions-an update to the hygiene hypothesis? Allergy 67: 451-461. http://dx.doi.org/10.1111/j.1398-9995.2011.02783.x.
4. Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C, Blanchard C, Junt T, Nicod LP, Harris NL, Marsland BJ. 2014. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 20:159-166. http://dx.doi.org/10.1038/nm.3444.
5. Frei R, Akdis M, O'Mahony L. 2015. Prebiotics, probiotics, synbiotics, and the immune system: experimental data and clinical evidence. Curr Opin Gastroenterol 31:153-158. http://dx.doi.org/10.1097/MOG.000000 0000000151.
6. Tomkovich S, Jobin C. 2016. Microbiota and host immune responses: a love-hate relationship. Immunology 147:1-10. http://dx.doi.org/10.1111/imm.12538.
7. Konieczna P, Akdis CA, Quigley EMM, Shanahan F, O'Mahony L. 2012. Portrait of an immunoregulatory Bifidobacterium. Gut Microbes 3:261-266. http://dx.doi.org/10.4161/gmic.20358.
8. O'Mahony C, Scully P, O'Mahony D, Murphy S, O'Brien F, Lyons A, Sherlock G, MacSharry J, Kiely B, Shanahan F, O'Mahony L. 2008. Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kB activation. PLoS Pathog 4:e1000112. http://dx.doi.org/10.1371/journal.ppat.1000112.
9. + T regulatory cells is protective in murine allergy models. Clin Exp Allergy 40: 811-819. http://dx.doi.org/10.1111/j.1365-2222.2009.03437.x.
10. McCarthy J, O'Mahony L, O'Callaghan L, Sheil B, Vaughan EE, Fitzsimons N, Fitzgibbon J, O'Sullivan GC, Kiely B, Collins JK, Shanahan F. 2003. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 52:975-980. http://dx.doi.org/10.1136/gut.52.7.975.
11. + T cell numbers. Cell Immunol 281:134-140. http://dx.doi.org/10.1016/j.cellimm.2013.03.008.
12. Symonds EL, O'Mahony C, Lapthorne S, O'Mahony D, Sharry JM, O'Mahony L, Shanahan F. 2012. Bifidobacterium infantis 35624 protects against salmonella-induced reductions in digestive enzyme activity in mice by attenuation of the host inflammatory response. Clin Transl Gastroenterol 3:e15. http://dx.doi.org/10.1038/ctg.2012.9.
13. Konieczna P, Groeger D, Ziegler M, Frei R, Ferstl R, Shanahan F, Quigley EMM, Kiely B, Akdis CA, O'Mahony L. 2012. Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells. Gut 61:354-366. http://dx.doi.org/10.1136/gutjnl-2011-300936.
14. Groeger D, O'Mahony L, Murphy EF, Bourke JF, Dinan TG, Kiely B, Shanahan F, Quigley EMM. 2013. Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut Microbes 4:325-339. http://dx.doi.org/10.4161/gmic.25487.
15. Konieczna P, Ferstl R, Ziegler M, Frei R, Nehrbass D, Lauener RP, Akdis CA, O'Mahony L. 2013. Immunomodulation by Bifidobacterium infantis 35624 in the murine lamina propria requires retinoic aciddependent and independent mechanisms. PLoS One 8:e62617. http://dx.doi.org/10.1371/journal.pone.0062617.
16. Sibartie S, O'Hara AM, Ryan J, Fanning A, O'Mahony J, O'Neill S, Sheil B, O'Mahony L, Shanahan F. 2009. Modulation of pathogen-induced CCL20 secretion from HT-29 human intestinal epithelial cells by commensal bacteria. BMC Immunol 10:54. http://dx.doi.org/10.1186/1471-2172-10-54.
17. O'Mahony L, O'Callaghan L, McCarthy J, Shilling D, Scully P, Sibartie S, Kavanagh E, Kirwan WO, Redmond HP, Collins JK, Shanahan F. 2006. Differential cytokine response from dendritic cells to commensal and pathogenic bacteria in different lymphoid compartments in humans. Am J Physiol Gastrointest Liver Physiol 290:G839-G845. http://dx.doi.org/10.1152/ajpgi.00112.2005.
18. + regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 107:12204-12209. http://dx.doi.org/10.1073/pnas.0909122107.
19. Dasgupta S, Erturk-Hasdemir D, Ochoa-Reparaz J, Reinecker HC, Kasper DL. 2014. Plasmacytoid dendritic cells mediate anti-inflammatory responses to a gut commensal molecule via both innate and adaptive mechanisms. Cell Host Microbe 15:413-423. http://dx.doi.org/10.1016/j.chom.2014.03.006.
20. Jones SE, Paynich ML, Kearns DB, Knight KL. 2014. Protection from intestinal inflammation by bacterial exopolysaccharides. J Immunol 192: 4813-4820. http://dx.doi.org/10.4049/jimmunol.1303369.
21. Fanning S, Hall LJ, Cronin M, Zomer A, MacSharry J, Goulding D, Motherway MO, Shanahan F, Nally K, Dougan G, van Sinderen D. 2012. Bifidobacterial surface-exopolysaccharide facilitates commensalhost interaction through immune modulation and pathogen protection. Proc Natl Acad Sci U S A 109:2108-2113. http://dx.doi.org/10.1073/pnas.1115621109.
22. Rossi O, Khan MT, Schwarzer M, Hudcovic T, Srutkova D, Duncan SH, Stolte EH, Kozakova H, Flint HJ, Samsom JN, Harmsen HJ, Wells JM. 2015. Faecalibacterium prausnitzii strain HTF-F and its extracellular polymeric matrix attenuate clinical parameters in DSS-induced colitis. PLoS One 10:e0123013. http://dx.doi.org/10.1371/journal.pone.0123013.
23. Altmann FAF, Kosma P, O'Callaghan A, Leahy S, Bottacini F, Molloy E, Plattner S, Schiavi E, Gleinser M, Groeger D, Grant R, Rodriguez Perez N, Healy S, Svehla E, Windwarder M, Hofinger A, O'Connell Motherway M, Akdis CA, Xu J, Roper J, van Sinderen D, O'Mahony L. 2016. Genome analysis and characterisation of the exopolysaccharide produced by Bifidobacterium longum subsp. longum 35624. PLoS One 11: e0162983. http://dx.doi.org/10.1371/journal.pone.0162983.
24. O'Riordan K, Fitzgerald GF. 1998. Evaluation of bifidobacteria for the production of antimicrobial compounds and assessment of performance in cottage cheese at refrigeration temperature. J Appl Microbiol 85:103-114. http://dx.doi.org/10.1046/j.1365-2672.1998.00474.x.
25. Maze A, O'Connell-Motherway M, Fitzgerald GF, Deutscher J, van Sinderen D. 2007. Identification and characterization of a fructose phosphotransferase system in Bifidobacterium breve UCC2003. Appl Environ Microbiol 73:545-553. http://dx.doi.org/10.1128/AEM.01496-06.
26. Law J, Buist G, Haandrikman A, Kok J, Venema G, Leenhouts K. 1995. A system to generate chromosomal mutations in Lactococcus lactis which allows fast analysis of targeted genes. J Bacteriol 177:7011-7018.
27. Alvarez-Martín P, O'Connell-Motherway M, van Sinderen D, Mayo B. 2007. Functional analysis of the pBC1 replicon from Bifidobacterium catenulatum L48. Appl Microbiol Biotechnol 76:1395-1402. http://dx.doi.org/10.1007/s00253-007-1115-5.
28. Masuko T, Minami A, Iwasaki N, Majima T, Nishimura SI, Lee YC. 2005. Carbohydrate analysis by a phenol-sulphuric acid method in microplate format. Anal Biochem 339:69-72. http://dx.doi.org/10.1016/j.ab.2004.12.001.
29. Arnold IC, Hutchings C, Kondova I, Hey A, Powrie F, Beverley P, Tchilian E. 2015. Helicobacter hepaticus infection in BALB/c mice abolishes subunit-vaccine-induced protection against M. tuberculosis. Vaccine 33:1808-1814. http://dx.doi.org/10.1016/j.vaccine.2015.02.041.
30. O'Connell Motherway M, O'Driscoll J, Fitzgerald GF, Van Sinderen D. 2009. Overcoming the restriction barrier to plasmid transformation and targeted mutagenesis in Bifidobacterium breve UCC2003. Microb Biotechnol 2:321-332. http://dx.doi.org/10.1111/j.1751-7915.2008.00071.x.
31. Hidalgo-Cantabrana C, Sanchez B, Alvarez-Martin P, Lopez P, Martinez-Alvarez N, Delley M, Marti M, Varela E, Suarez A, Antolin M, Guarner F, Berger B, Ruas-Madiedo P, Margolles A. 2015. A single mutation in the gene responsible for the mucoid phenotype of Bifidobacterium animalis subsp. lactis confers surface and functional characteristics. Appl Environ Microbiol 81:7960-7968. http://dx.doi.org/10.1128/AEM.02095-15.
32. Egan M, O'Connell Motherway M, Ventura M, van Sinderen D. 2014. Metabolism of sialic acid by Bifidobacterium breve UCC2003. Appl Environ Microbiol 80:4414-4426. http://dx.doi.org/10.1128/AEM.01114-14.
33. O'Connell Motherway M, Kinsella M, Fitzgerald GF, van Sinderen D. 2013. Transcriptional and functional characterization of genetic elements involved in galacto-oligosaccharide utilization by Bifidobacterium breve UCC2003. Microb Biotechnol 6:67-79. http://dx.doi.org/10.1111/1751-7915.12011.
34. van der Kleij H, O'Mahony C, Shanahan F, O'Mahony L, Bienenstock J. 2008. Protective effects of Lactobacillus reuteri and Bifidobacterium infantis in murine models for colitis do not involve the vagus nerve. Am J Physiol Regul Integr Comp Physiol 295:R1131-R1137. http://dx.doi.org/10.1152/ajpregu.90434.2008.
35. Lu S, Li H, Gao R, Gao X, Xu F, Wang Q, Lu G, Xia D, Zhou J. 2016. IL-17A, but not IL-17F, is indispensable for airway vascular remodeling induced by exaggerated Th17 cell responses in prolonged ovalbuminchallenged mice. J Mol Med (Berl) 194:3557-3566.
36. Salazar N, Ruas-Madiedo P, Kolida S, Collins M, Rastall R, Gibson G, de los Reyes-Gavilán CG. 2009. Exopolysaccharides produced by Bifidobacterium longum IPLA E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify the composition and metabolic activity of human faecal microbiota in pH-controlled batch cultures. Int J Food Microbiol 135: 260-267. http://dx.doi.org/10.1016/j.ijfoodmicro.2009.08.017.
37. Alp G, Aslim B. 2010. Relationship between the resistance to bile salts and low pH with exopolysaccharide (EPS) production of Bifidobacterium spp. isolated from infants feces and breast milk. Anaerobe 16:101-105. http://dx.doi.org/10.1016/j.anaerobe.2009.06.006.
38. Salazar N, Gueimonde M, de los Reyes-Gavilán CG, Ruas-Madiedo P. 2016. Exopolysaccharides produced by lactic acid bacteria and bifidobacteria as fermentable substrates by the intestinal microbiota. Crit Rev Food Sci Nutr 56:1440-1453. http://dx.doi.org/10.1080/10408398.2013.770728.
39. Conover MS, Sloan GP, Love CF, Sukumar N, Deora R. 2010. The Bps polysaccharide of Bordetella pertussis promotes colonization and biofilm formation in the nose by functioning as an adhesin. Mol Microbiol 77: 1439-1455. http://dx.doi.org/10.1111/j.1365-2958.2010.07297.x.
40. Xu CL, Wang YZ, Jin ML, Yang XQ. 2009. Preparation, characterization and immunomodulatory activity of selenium-enriched exopolysaccharide produced by bacterium Enterobacter cloacae Z0206. Bioresour Technol 100:2095-2097. http://dx.doi.org/10.1016/j.biortech.2008.10.037.
41. Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, Mazmanian SK. 2011. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332:974-977. http://dx.doi.org/10.1126/science.1206095.
42. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. 2005. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122:107-118. http://dx.doi.org/10.1016/j.cell.2005.05.007.
43. Mazmanian SK, Round JL, Kasper DL. 2008. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453:620-625. http://dx.doi.org/10.1038/nature07008.
44. Yasuda E, Serata M, Sako T. 2008. Suppressive effect on activation of macrophages by Lactobacillus casei strain Shirota genes determining the synthesis of cell wall-associated polysaccharides. Appl Environ Microbiol 74:4746-4755. http://dx.doi.org/10.1128/AEM.00412-08.
45. Chapot-Chartier M-P, Kulakauskas S. 2014. Cell wall structure and function in lactic acid bacteria. Microb Cell Fact 13:S9. http://dx.doi.org/10.1186/1475-2859-13-S1-S9.
46. Ruiz L, Hevia A, Bernardo D, Margolles A, Sánchez B. 2014. Extracellular molecular effectors mediating probiotic attributes. FEMS Microbiol Lett 359:1-11. http://dx.doi.org/10.1111/1574-6968.12576.
47. Konstantinov SR, Smidt H, de Vos WM, Bruijns SCM, Singh SK, Valence F, Molle D, Lortal S, Altermann E, Klaenhammer TR, van Kooyk Y. 2008. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc Natl Acad Sci U S A 105:19474-19479. http://dx.doi.org/10.1073/pnas.0810305105.
48. Al-Hassi HO, Mann ER, Sanchez B, English NR, Peake STC, Landy J, Man R, Urdaci M, Hart AL, Fernandez-Salazar L, Lee GH, Garrote JA, Arranz E, Margolles A, Stagg AJ, Knight SC, Bernardo D. 2014. Altered human gut dendritic cell properties in ulcerative colitis are reversed by Lactobacillus plantarum extracellular encrypted peptide STp. Mol Nutr Food Res 58:1132-1143. http://dx.doi.org/10.1002/mnfr.201300596.
49. Yan F, Cao H, Cover TL, Washington MK, Shi Y, Liu L, Chaturvedi R, Peek RM, Wilson KT, Polk DB. 2011. Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J Clin Invest 121:2242-2253. http://dx.doi.org/10.1172/JCI44031.
50. Korn T, Bettelli E, Oukka M, Kuchroo VK. 2009. IL-17 and Th17 cells. Annu Rev Immunol 27:485-517. http://dx.doi.org/10.1146/annurev.immunol.021908.132710.
51. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. 2006. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-151. Veld7-producing T cells. Immunity 24:179-189. http://dx.doi.org/10.1016/j.immuni.2006.01.001.
52. Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E, Klunker S, Meyer N, O'Mahony L, Palomares O, Rhyner C, Ouaked N, Schaffartzik A, Van De Veen W, Zeller S, Zimmermann M, Akdis CA. 2011. Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. J Allergy Clin Immunol 127:701-721. http://dx.doi.org/10.1016/j.jaci.2010.11.050.
53. Gálvez J. 2014. Role of Th17 cells in the pathogenesis of human IBD. ISRN Inflamm 2014:928461. http://dx.doi.org/10.1155/2014/928461.
54. Hidalgo-Cantabrana C, Lopez P, Gueimonde M, de Los Reyes-Gavilan CG, Suarez A, Margolles A, Ruas-Madiedo P. 2012. Immune modulation capability of exopolysaccharides synthesised by lactic acid bacteria and bifidobacteria. Probiotics Antimicrob Proteins 4:227-237. http://dx.doi.org/10.1007/s12602-012-9110-2.
55. Margolles A, Florez AB, Moreno JA, van Sinderen D, de los Reyes-Gavilan CG. 2006. Two membrane proteins from Bifidobacterium breve UCC2003 constitute an ABC-type multidrug transporter. Microbiology 152:3497-3505. http://dx.doi.org/10.1099/mic.0.29097-0.